SCHEMBL27460802

SCHEMBL27460802

CC(N)C(=O)C1(c2ccccc2)CNCCO1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
HTR2A P28223 1/20 0.34
OPRM1 P35372 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 1/20 0.32
ELANE P08246 1/20 0.32
SLC6A2 P23975 4/20 0.31
SLC6A3 Q01959 3/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
OPRL1 P41146 1/20 0.31
SLC6A4 P31645 2/20 0.30
TDP1 Q9NUW8 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ITGB1 P05556 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28767790 0.83 HTR2A (0.40) ALDH1A1HTR2AOPRM1TSHRSLC6A2
SCHEMBL2447412 0.81 HTR2A (0.39) HTR2AOPRM1TSHRSLC6A2SLC6A3
SCHEMBL29240149 0.81 HTR2A (0.41) ALDH1A1HTR2AOPRM1TSHRSLC6A2
SCHEMBL28745569 0.77 HTR2A (0.40) HTR2AOPRM1TSHRSLC6A2SLC6A3
SCHEMBL28805981 0.76 OPRM1 (0.37) ALDH1A1HTR2AOPRM1L3MBTL1TSHR
SCHEMBL15410302 0.75 HTR2A (0.36) HTR2AOPRM1TSHRSLC6A2SLC6A3
SCHEMBL15090448 0.74 ALDH1A1 (0.31) ALDH1A1OPRM1KDM4ETSHRSLC6A2
SCHEMBL5385849 0.68 HDAC4 (0.37) ALDH1A1HTR2AOPRM1SLC6A2SLC6A3
SCHEMBL10880376 0.68 OPRM1 (0.37) ALDH1A1HTR2AOPRM1TSHRSLC6A2
SCHEMBL27825135 0.68 TSHR (0.39) HTR2AOPRM1TSHRSLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1125054-C Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them AVENTIS PHARMACEUTICS GMBH (DE) 2003-10-22 CN disclosed